Cronos Group Inc

Most Recent

  • cbd stocks to watch
    Cannabis

    Investment Radar — Top CBD Stocks to Watch

    By Sushree Mohanty
  • uploads///AdobeStock_
    Consumer

    Will Altria’s Q2 Earnings Be a Boom or Bust?

    Analysts expect Altria to report revenues of $5.08 billion in the second quarter of 2020—a fall of 2.2% from $5.19 billion in the second quarter of 2019.

    By Rajiv Nanjapla
  • uploads///marijuana montana
    Cannabis

    Marijuana Legalization Proceeds in Montana amid COVID-19

    New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.

    By Sushree Mohanty
  • uploads///Organigram
    Cannabis

    Haywood Capital Markets Reduced OrganiGram’s Target Price

    OrganiGram (NASDAQ:OGI) stock is trading higher before its third-quarter earnings. The stock closed with a gain of 3.9% at $1.58 on Wednesday.

    By Sushree Mohanty
  • uploads///dea
    Cannabis

    Analyzing the Top 3 CBD Companies to Buy in July

    Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    Barclays Downgrades Altria, Worries about Declining Market Share

    Today, Gaurav Jain of Barclays downgraded Altria Group (NYSE:MO) from “overweight” to “equal weight.” He also lowered his target price from $50 to $43.

    By Rajiv Nanjapla
  • uploads///innovative industrial properties cash
    Cannabis

    Innovative Industrial Properties Raises More Cash amid Crisis

    On June 30, Innovative Industrial Properties announced its decision to raise additional capital of $225 million through a public offering of its common stock.

    By Sushree Mohanty
  • uploads///marijuana stocks july
    Cannabis

    What to Expect from Marijuana Stocks in July

    OrganiGram will likely report its earnings for the third quarter of fiscal 2020 on July 13. We’ll have to see if marijuana stocks recover in July.

    By Sushree Mohanty
  • uploads///Acb_
    Cannabis

    Why Did Raymond James Downgrade OrganiGram?

    On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

    By Rajiv Nanjapla
  • uploads///cronos group raymond james bullish
    Cannabis

    Why Is Raymond James Bullish on Cronos Group?

    Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”

    By Rajiv Nanjapla
  • uploads///aurora cannabis analysts bullish
    Cannabis

    Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish

    Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.

    By Sushree Mohanty
  • uploads///south dakota marijuana
    Cannabis

    Marijuana Legalization in South Dakota Lies with Voters Now

    Marijuana legalization in South Dakota could see daylight in 2020. The state passed measures to legalize both recreational and medical marijuana.

    By Sushree Mohanty
  • uploads///virgin islands marijuana legalization
    Cannabis

    U.S. Virgin Islands’ Governor Supports Marijuana Legalization

    While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.

    By Sushree Mohanty
  • uploads///hexo mixed results
    Cannabis

    Hexo Beat the Revenue Estimates, Posted Q3 Loss

    Hexo beat the revenue estimates of 19.9 million Canadian dollars. However, the company reported a quarterly EBITDA loss of 4.3 million Canadian dollars.

    By Sushree Mohanty
  • uploads///hexo pass
    Cannabis

    Why Lorne Steinberg Thinks Hexo Is a Pass

    Lorne Steinberg thinks that even after Hexo’s deal with Molson Coors, it still doesn’t look attractive. He would rather find value somewhere else.

    By Sushree Mohanty
  • uploads///cigarette and cannabis sales
    Cannabis

    How’s COVID-19 Impacting Cigarette and Cannabis Sales?

    Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    How Do Philip Morris and Altria Compare in 2020?

    So far this year, Philip Morris International (NYSE:PM) and Altria Group (NYSE:MO) have underperformed the broader equity markets.

    By Rajiv Nanjapla
  • uploads///canopy growth cannabis
    Cannabis

    Canopy Growth: New Cannabis 2.0 Products amid COVID-19

    Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.

    By Sushree Mohanty
  • uploads///tilray analysts take
    Cannabis

    What Do Analysts Think about Tilray after Its Q1 Results?

    Tilray (NASDAQ:TLRY) posted its first-quarter earnings on May 11. The revenue growth was impressive in the first quarter.

    By Sushree Mohanty
  • uploads///hexo clock
    Cannabis

    Hexo Receives NYSE Warning for Listing, Clock Is Ticking

    On April 7, the NYSE sent a listing notification to Hexo. The warning said that the stock fell below the NYSE’s $1.00 share price continued listing standard.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Stock Surged 68% on May 15

    Aurora Cannabis (NYSE:ACB) reported its third-quarter results on May 14. The earnings report was a surprise for most analysts and investors.

    By Sushree Mohanty
  • uploads///aurora cannabis q results announce
    Cannabis

    Aurora Cannabis: Q3 Revenue Beat the Estimates

    Aurora Cannabis saw less of an impact from COVID-19 in the third quarter. Cannabis is an essential item amid the pandemic.

    By Sushree Mohanty
  • uploads///cannabis relief
    Cannabis

    Marijuana: Banking Access Included in Coronavirus Relief Bill

    Marijuana companies in the US have been struggling to get financial and banking access. Cannabis still isn’t legal at the federal level.

    By Sushree Mohanty
  • uploads///green thumb store
    Cannabis

    New Cannabis Store Opens before Green Thumb’s Q1 Earnings

    Green Thumb Industries (OTCMKTS:GTBIF) will likely report its results for the first quarter of fiscal 2020 on May 14 after the market closes. 

    By Sushree Mohanty
  • uploads///cronos group earnings and outlook
    Cannabis

    Cronos: Analysts Cut Target Price, Raymond James Still Bullish

    Cronos Group (NASDAQ:CRON) reported its results for the first quarter of fiscal 2020 on May 8. The revenue growth was stronger.

    By Sushree Mohanty
  • uploads///aurora cannabis q results
    Cannabis

    Aurora Cannabis to Report Q3 Earnings, Stock Falls after Split

    Aurora Cannabis (NYSE:ACB) announced a reverse stock split in April. The stock split happened on Monday and the stock took a hit.

    By Sushree Mohanty
  • uploads///cronos group higher sales
    Cannabis

    Cronos Group’s Q1 Revenue Driven by Higher Marijuana Sales

    Cronos Group (NASDAQ:CRON) reported its results for the first quarter of fiscal 2020 on May 8. The revenue improved from the fourth quarter of fiscal 2019.

    By Sushree Mohanty
  • uploads///aphria stock fell
    Cannabis

    Why Did Aphria Stock Fall 7% on May 8?

    On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.

    By Rajiv Nanjapla
  • uploads///marijuana new zealand
    Cannabis

    Marijuana Legalization: New Zealand Has a Final Proposal

    In New Zealand, marijuana legalization’s fate depends on the September general elections. The country has a final bill to put on the ballot.

    By Sushree Mohanty
  • uploads///tilray_
    Cannabis

    Tilray’s Q1 Earnings Could Boost Its Stock Price

    The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.

    By Rajiv Nanjapla
  • uploads///APH_
    Cannabis

    Why Has Aphria Risen in Today’s Pre-Trading Hours?

    Today, Aphria (NYSE:APHA) announced that ASG Pharma has received EU GMP certification to produce cannabis for medical and research purposes.

    By Rajiv Nanjapla
  • uploads///cronos group downgrade
    Cannabis

    Raymond James Downgraded Cronos before Its Q1 Earnings

    Cronos Group (NASDAQ:CRON) will likely report its results for the first quarter of fiscal 2020 on May 8 before the market opens.

    By Sushree Mohanty
  • uploads///cannabis legalization nebraska
    Cannabis

    Marijuana Legalization in Nebraska Has a New Strategy

    Marijuana campaigns have struggled to gather signatures amid the coronavirus pandemic. However, there’s still some hope in Nebraska.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Constellation Brands Hikes Its Stake in Canopy Growth

    Constellation Brands (NYSE:STZ) expressed its confidence in Canopy Growth (NYSE:CGC)(TSE:WEED) by increasing its stake in the company.

    By Rajiv Nanjapla
  • uploads///Cronos Group
    Cannabis

    How Do Analysts Rate Cronos Group?

    As of April 29, Cronos Group was trading at 8.63 Canadian dollars—a fall of 4.3% since the company reported its fourth-quarter earnings.

    By Rajiv Nanjapla
  • uploads///altria upcoming earnings
    Consumer

    What Can Investors Expect from Altria’s Q1 Results?

    Currently, 14 analysts cover Altria stock. Many analysts have a bullish view on the stock due to its higher dividend yield and lower valuation.

    By Sushree Mohanty
  • uploads///marijuana legalization new jersey
    Cannabis

    Marijuana Legalization Referendum Ready for Voting in New Jersey

    Marijuana legalization laws have failed numerous times in New Jersey. There’s a lot of support to legalize recreational cannabis in the state.

    By Sushree Mohanty
  • uploads///marijuana new york
    Cannabis

    New York Lawmakers Want to Legalize Marijuana via Zoom

    The marijuana legalization topic might not have ended completely in New York. Governor Cuomo thinks that lawmakers might pass the legislation remotely.

    By Sushree Mohanty
  • uploads///aphria mixed reactions
    Cannabis

    Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings

    On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///tilray jefferies downgrade
    Cannabis

    Tilray Falls 6% after Jefferies Downgraded the Stock

    Jefferies went bullish on Aphria and bearish on Tilray. Notably, Tilray stock fell 6% on Thursday after Jefferies downgraded the stock.

    By Sushree Mohanty
  • uploads///organigram stock weak results
    Cannabis

    Wall Street Is Bearish after OrganiGram’s Q2 Results

    OrganiGram’s second-quarter results didn’t meet the expectations. Many analysts downgraded the stock and cut the target price.

    By Sushree Mohanty
  • uploads///organigram second quarter results
    Cannabis

    OrganiGram Posted Its Q2 Earnings, Stock Fell 12%

    OrganiGram (NASDAQ:OGI) reported its results for the second quarter of fiscal 2020 on April 14 before the market opened. The results weren’t impressive.

    By Sushree Mohanty
  • uploads///aphria results
    Cannabis

    Aphria Reported Impressive Q3 Results, Beat Expectations

    On Tuesday, Aphria (NYSE:APHA) reported its third-quarter results. The company reported impressive third-quarter results and beat analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///cannabis problem solution
    Cannabis

    Cannabis Faces Barriers in Washington and Michigan

    Washington has included cannabis on the list of essential items. However, the COVID-19 crisis has caused the state to make some strict changes.

    By Sushree Mohanty
  • uploads///organigram q results
    Cannabis

    OrganiGram: Analysts Aren’t Hopeful about Its Q2 Earnings

    OrganiGram will report its results for the second quarter of fiscal 2020 on April 14 before the market opens. Analysts aren’t hopeful about the results.

    By Sushree Mohanty
  • uploads///joe biden marijuana
    Cannabis

    Should Joe Biden Support Marijuana Legalization?

    Marijuana is gaining a lot of attention amid the coronavirus pandemic. Many people think that Joe Biden should support marijuana legalization.

    By Sushree Mohanty
  • uploads///kushco
    Cannabis

    KushCo Posted Disappointing Q2 Results, Stock Rose 8%

    KushCo’s second-quarter revenue was almost in line with analysts’ estimates. The company reported revenue of $30.14 million.

    By Sushree Mohanty
  • uploads///Aphria_
    Cannabis

    Will Aphria’s Q3 Earnings Lift the Cannabis Sector?

    Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.

    By Rajiv Nanjapla
  • uploads///organigram analysts revise
    Cannabis

    OrganiGram: Analysts Revise 2020 Estimates in April

    Analysts have lowered the revenue estimates for OrganiGram for fiscal 2020. Analysts expect the revenue to be around 127 million Canadian dollars.

    By Sushree Mohanty
  • uploads///HEXO
    Cannabis

    Hexo Looks to Raise Additional Capital amid Falling Stock

    Hexo stock fell to a low of 0.68 Canadian dollars and closed Wednesday at 0.71 Canadian dollars. The stock fell by 26% from Tuesday’s closing price.

    By Rajiv Nanjapla
  • uploads///marijuana survive covid
    Cannabis

    Will the Marijuana Industry Survive COVID-19?

    Despite increased sales, the marijuana industry’s struggles haven’t ended. Temporarily closing stores and laying off employees will take a toll.

    By Sushree Mohanty
  • uploads///tilray survive coronavirus
    Cannabis

    Will Tilray Recover in 2020 amid the COVID-19 Outbreak?

    Tilray (NASDAQ:TLRY) had a disastrous 2019—the stock lost 75.7% of its value. So far, 2020 hasn’t been pretty either for the stock.

    By Sushree Mohanty
  • uploads///marijauna business relief
    Cannabis

    Cannabis Sector Gets Support for Federal Business Relief

    Marijuana provides employment opportunities and tax revenue to the states. However, cannabis companies don’t get federal business relief during COVID-19.

    By Sushree Mohanty
  • uploads///cronos group revision
    Cannabis

    Cronos Group: Analysts Revise Estimates in April

    Cronos Group disappointed analysts and investors with its results for the fourth quarter of fiscal 2019. The company missed analysts’ revenue estimates.

    By Sushree Mohanty
  • uploads///weed cron coronavirus
    Cannabis

    Bruce Linton: WEED and CRON Can Handle COVID-19 Storm

    On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.

    By Rajiv Nanjapla
  • uploads///north dakota marijuana coronavirus
    Cannabis

    COVID-19 Killed North Dakota’s Marijuana Legalization Dreams

    North Dakota has struggled to gather signatures amid the coronavirus outbreak. As a result, the state suspended its marijuana legalization campaign.

    By Sushree Mohanty
  • uploads///marijuana stocks april
    Cannabis

    What Can You Expect from Marijuana Stocks in April?

    As of April 3, Aurora Cannabis stock has fallen 10%, while Canopy Growth has fallen 8.1%. Cronos Group and Hexo have fallen 2.6% and 19.3% in April.

    By Sushree Mohanty
  • uploads///idaho cannabis legalization
    Cannabis

    Idaho Suspends Marijuana Legalization amid Coronavirus

    Medical marijuana legalization won’t happen in Idaho in 2020 due to the coronavirus pandemic. The ICC couldn’t gather the required signatures.

    By Sushree Mohanty
  • uploads///new york marijuana
    Cannabis

    Marijuana Legalization Won’t Happen in New York in 2020

    New York lawmakers decided to delay marijuana legalization due to the COVID-19 pandemic. As a result, New York won’t see marijuana legalization in 2020.

    By Sushree Mohanty
  • uploads///massachusetts cannabis sales
    Cannabis

    Massachusetts: No Adult-Use Cannabis Sales amid COVID-19

    Cannabis sales continue to rise due to increased demand amid the coronavirus outbreak. Globally, the coronavirus chaos has caused panic and anxiety.

    By Sushree Mohanty
  • uploads///cronos group analysts bearish
    Cannabis

    Cronos Group: Wall Street Is Bearish after Its Earnings

    Cronos Group (NASDAQ:CRON) disappointed investors with its fourth-quarter results on March 30. The company’s revenue was way below analysts’ estimates.

    By Sushree Mohanty
  • uploads///medmen withdraw
    Cannabis

    MedMen Withdrew Its Guidance amid COVID-19 Pandemic

    MedMen stock fell by 12.0% on March 30 after the company released some corporate updates. MedMen has been struggling with a cash crunch.

    By Sushree Mohanty
  • uploads///cronos group shipwreck
    Cannabis

    Why Were Cronos Group’s Q4 Earnings a Shipwreck?

    Cronos Group reported its fourth-quarter and fiscal 2019 results on Monday after the market closed. The company’s fourth-quarter results were disappointing.

    By Sushree Mohanty
  • uploads///cronos group earnings expectations
    Cannabis

    What to Expect from Cronos Group’s Q4 Earnings Today

    Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.

    By Sushree Mohanty
  • uploads///cannabis missouri
    Cannabis

    Marijuana Legalization in Missouri amid COVID-19?

    Marijuana legalization efforts in the US have slowed down because of the coronavirus outbreak. Missouri was determined to legalize marijuana in 2020.

    By Sushree Mohanty
  • uploads///hexo stock rose delisting
    Cannabis

    Hexo Stock Rose, Will It Still Get Delisted?

    Hexo (TSE:HEXO) stock closed 41.3% higher on March 26. So far this week, the stock has risen 59.2%. Hexo faced getting delisted from the exchange.

    By Sushree Mohanty
  • uploads///cannabis stocks broader market
    Cannabis

    Cannabis Stocks Outperformed Broader Equity Markets Last Week

    Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.

    By Rajiv Nanjapla
  • uploads///hexo current storm
    Cannabis

    Hexo Stock Faces a Storm, Will It Rebound?

    Hexo (TSE:HEXO) closed with a loss of 19% on March 18. The stock started its downward trend on Tuesday. The company decided to delay its second-quarter earnings.

    By Sushree Mohanty
  • uploads///canopy growth store closings
    Cannabis

    Canopy Growth Temporarily Closes Its Retail Outlets

    On Tuesday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it will temporarily close all of its company-owned Tokyo Smoke and Tweed retail stores.

    By Rajiv Nanjapla
  • uploads///ACB_
    Cannabis

    Terry Booth Cuts His Stake in Aurora Cannabis

    On Monday, Aurora Cannabis (NYSE:ACB) announced that its founder and former CEO, Terry Booth, sold approximately 12.2 million shares in the open market.

    By Rajiv Nanjapla
  • uploads///Hexo stock delisting
    Cannabis

    Cannabis Stock: Will Hexo Get Delisted Next?

    Hexo (TSE:HEXO) has been struggling for a while now. The string of bad news started in October 2019 when CFO Michael Monahan resigned.

    By Sushree Mohanty
  • uploads///sundial growers stock
    Cannabis

    Can Sundial Growers’ New Management Save Its Stock?

    Sundial Growers isn’t a big name in the cannabis sector. However, the company has a variety of cannabis products, which earned it a name in the space.

    By Sushree Mohanty
  • uploads///alabama medical marijuana bill
    Cannabis

    Alabama Gets Closer to Legalizing Medical Marijuana

    On Thursday, WBRC reported that the Alabama Senate cleared Senate Bill 165. The bill will create the Compassion Act, which legalizes medical marijuana.

    By Rajiv Nanjapla
  • uploads///aurora cannabis deslisting
    Cannabis

    Aurora Cannabis Falls 60% in 2020, Might Get Delisted

    Aurora Cannabis (NYSE:ACB) stock has fallen below $1 on the NYSE, which puts it at the risk of being delisted from the exchange.

    By Sushree Mohanty
  • uploads///canada marijuana legalization un
    Cannabis

    Canada Responds to UN, Defends Marijuana Legalization

    Recently, the UN questioned whether marijuana legalization has benefited Canada. The Canadian government defended its position.

    By Sushree Mohanty
  • uploads///canopy growth attractive buy
    Cannabis

    Does Canopy Growth Look Attractive after Yesterday’s Fall?

    Canopy Growth (NYSE:CGC)(TSE:WEED) has lost 33.9% of its stock value this year. So, did yesterday’s fall make the stock an attractive buy?

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Could Reduce Illegal Market Demand

    The marijuana legalization process in US states is speeding up in 2020. Many new states are coming up with their own proposals to legalize marijuana.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Consumer

    Should You Consider Buying Altria Group?

    As of March 6, Altria Group (NYSE:MO) was trading at $42.15—a fall of 15.9% since the company reported its earnings for the fourth quarter of 2020 on January 30.

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana Sales Rise in Illinois, Other States Notice

    Marijuana became legal in Illinois on January 1, 2020. As expected, retail cannabis sales started soaring as soon as legal shops opened their doors.

    By Sushree Mohanty
  • uploads///CRON_
    Cannabis

    Cronos Group Receives Rare ‘Buy’ Rating from MKM Partners

    MKM Partners analyst Bill Kirk likes Cronos Group’s healthy cash position, strong track record, and its relationship with Altria (NYSE:MO).

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Will Coronavirus Target the Marijuana Industry Next?

    Cannabis companies that have operations in China, especially the ones that manufacture vape products, have been impacted by the coronavirus.

    By Sushree Mohanty
  • uploads///organigram analysts recommendations
    Cannabis

    OrganiGram: What Do Analysts Recommend Right Now?

    As of February 28, OrganiGram Holdings (NASDAQ:OGI) was trading at 2.98 Canadian dollars—a fall of 6.6% since the beginning of this year.

    By Rajiv Nanjapla
  • uploads///canopy growth why invest
    Cannabis

    Should You Consider Buying Canopy Growth?

    As of February 28, Canopy Growth (NYSE:CGC)(TSE:WEED) was trading at 25.17 Canadian dollars. So far, the company has lost 7.8% of its stock value YTD.

    By Rajiv Nanjapla
  • uploads///Cronos
    Cannabis

    Cronos Group Stock Falls after Delay in Its Q4 Earnings

    Cronos Group was going to report its Q4 earnings before the market opens on Thursday. However, the company announced a delay in its earnings release.

    By Sushree Mohanty
  • uploads///Acb_
    Cannabis

    Why Did Cowen Downgrade Aurora Cannabis?

    On Monday, MarketWatch reported that Cowen downgraded Aurora Cannabis from “outperform” to “market perform” and lowered the target price.

    By Rajiv Nanjapla
  • uploads///hemp_
    Cannabis

    HEXO Stock Fell after a Downgrade from Jefferies

    On February 21, HEXO fell to a low of 1.40 Canadian dollars and closed at 1.41 Canadian dollars. The stock fell 2.1% from the previous day’s closing price.

    By Rajiv Nanjapla
  • uploads///OGI_pic
    Cannabis

    What to Expect from Cronos Group’s Q4 Earnings

    Cronos Group will report its fourth-quarter earnings before the market opens on Thursday. Analysts expect double-digit revenue growth sequentially.

    By Rajiv Nanjapla
  • uploads///Joe Biden
    Cannabis

    Trump Administration Wants to Keep Marijuana Illegal

    President Trump’s re-election campaign spokesperson said that the administration thinks that marijuana and other drugs should be illegal.

    By Sushree Mohanty
  • uploads///curaleaf__
    Cannabis

    Why Is PI Financial Bullish on Cronos Group?

    Jason Zandberg of PI Financial reiterated its “buy” rating for Cronos Group. He also maintained his target price of 17 Canadian dollars for the stock.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Aurora Cannabis: Analysts Cut Target Prices after Its Q2 Earnings

    Aurora Cannabis reported its results for the second quarter of fiscal 2020 on February 13. The company reported revenues of 56.0 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///mexico cannabis
    Cannabis

    Will Mexico Legalize Marijuana This Month?

    Mexico might finally see cannabis legalization by the end of this month. The Mexico Supreme Court extended the deadline to April 30.

    By Sushree Mohanty
  • uploads///aurora cannabis q results
    Cannabis

    Aurora Cannabis Missed Analysts’ Expectations in Q2

    For the second quarter, Aurora Cannabis reported net revenues of 56.0 million Canadian dollars, which fell short of analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///aurora cannabis upcoming results
    Cannabis

    Are You Ready for ACB’s Earnings Today?

    Aurora Cannabis (NYSE:ACB) will report its results for the second quarter of fiscal 2020 today before the market opens. Investors will be watching closely.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Can Aurora Cannabis Regain Investors’ Trust?

    Aurora Cannabis will likely report its Q2 results on Thursday before the market opens. In the last two weeks, the company delivered disappointing news.

    By Sushree Mohanty
  • uploads///mariju
    Cannabis

    Marijuana Vape Products Expected in Alberta Stores

    AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

    By Rajiv Nanjapla
  • uploads///AuroraCannabis
    Cannabis

    ACB Made Analysts Skeptical, Stock Took a Massive Hit

    Aurora Cannabis started 2020 with a lot of bad news. The company announced job cuts last week, which impacted its profitability.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Singapore Government Asks Netflix to Block Marijuana Shows

    Some countries still have very strict marijuana laws. Recently, Singapore’s government asked Netflix to block all marijuana shows and films in the country.

    By Sushree Mohanty
  • uploads///CL_
    Cannabis

    What to Expect from Canopy Growth’s Q3 Earnings?

    Canopy Growth will report its earnings for the third quarter of fiscal 2020 before the market opens on Friday. Analysts expect the revenue to rise.

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Why Kentucky Residents Favor Marijuana Legalization

    More Kentucky residents favor marijuana legalization. According to a poll, 90% of the respondents favor medical marijuana compared to 78% in 2012.

    By Rajiv Nanjapla
  • uploads///acb preliminary results
    Cannabis

    ACB Announces Q2 Preliminary Results, CEO Retires

    ACB provided unaudited preliminary results for its second-quarter earnings on Thursday. The cannabis revenue could be 62 million–66 million Canadian dollars.

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.